Mutations in hnRNPA1 promote irreversible amyloid formation and impair droplet dynamics, potentially leading to pathological protein aggregationDysregulated PARylation contributes to hnRNPA1 aggregation and neurodegenerative disease. Here, HNRNPA1 is linked to neurodegenerative disease.